Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF)
1.875
-0.26
(-12.38%)
USD |
OTCM |
Nov 17, 16:00
Shanghai Fosun Pharmaceutical Enterprise Value : 11.14B for Nov. 17, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 17, 2026 | 11.14B |
| November 16, 2026 | 11.84B |
| November 13, 2026 | 11.84B |
| November 12, 2026 | 11.84B |
| November 11, 2026 | 11.84B |
| November 10, 2026 | 11.84B |
| November 09, 2026 | 11.84B |
| November 06, 2026 | 11.84B |
| November 05, 2026 | 11.84B |
| November 04, 2026 | 11.89B |
| November 03, 2026 | 11.93B |
| November 02, 2026 | 11.93B |
| October 30, 2026 | 11.93B |
| October 29, 2026 | 11.93B |
| October 28, 2026 | 11.93B |
| October 27, 2026 | 11.93B |
| October 26, 2026 | 11.93B |
| October 23, 2026 | 11.93B |
| October 22, 2026 | 11.93B |
| October 21, 2026 | 11.93B |
| October 20, 2026 | 11.93B |
| October 19, 2026 | 11.93B |
| October 16, 2026 | 12.65B |
| October 15, 2026 | 12.65B |
| October 14, 2026 | 12.65B |
| Date | Value |
|---|---|
| October 13, 2026 | 12.65B |
| October 12, 2026 | 12.65B |
| October 09, 2026 | 12.65B |
| October 08, 2026 | 12.65B |
| October 07, 2026 | 12.65B |
| October 06, 2026 | 12.65B |
| October 05, 2026 | 12.65B |
| October 02, 2026 | 12.65B |
| October 01, 2026 | 12.65B |
| September 30, 2026 | 12.65B |
| September 29, 2026 | 12.09B |
| September 28, 2026 | 12.09B |
| September 25, 2026 | 11.43B |
| September 24, 2026 | 11.43B |
| September 23, 2026 | 11.43B |
| September 22, 2026 | 11.43B |
| September 21, 2026 | 11.43B |
| September 18, 2026 | 11.43B |
| September 17, 2026 | 11.43B |
| September 16, 2026 | 11.43B |
| September 15, 2026 | 11.43B |
| September 14, 2026 | 10.72B |
| September 11, 2026 | 10.72B |
| September 10, 2026 | 11.43B |
| September 09, 2026 | 11.43B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
Enterprise Value Related Metrics
| Net Income (Quarterly) | 162.89M |
| Revenue (Quarterly) | 1.486B |
| Total Expenses (Quarterly) | 1.346B |
| EPS Diluted (Quarterly) | 0.0532 |
| Gross Profit Margin (Quarterly) | 49.79% |
| Profit Margin (Quarterly) | 10.96% |
| Earnings Yield | 10.31% |
| Operating Earnings Yield | 8.03% |
| Normalized Earnings Yield | 9.205 |